Oncotype DX Helps Avoid Unnecessary Chemo in Breast Cancer

1 source1 article First seen 3 hours ago Updated 3 hours ago France Truth score 38

Save Like Comments Compare coverage

Summary

French real-world data suggest that genomic testing can help de-escalate chemotherapy in early-stage breast cancer without compromising outcomes. Medscape News Europe

Description from Medscape.

Who is covering this

Medscape Center Factuality: Mostly factual US 3 hours ago
Oncotype DX Helps Avoid Unnecessary Chemo in Breast Cancer
French real-world data suggest that genomic testing can help de-escalate chemotherapy in early-stage breast cancer without compromising outcomes. Medscape News Europe

Comments

Comments need JavaScript.

Truth score

38/100Weakly supported

Independent outlets: 1
Source reliability: 65/100
Sides of the spectrum covering it: 1/3
Propaganda risk: 0/100

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Coverage by lean

Centre 100%100%

Left: 0
Centre: 1
Right: 0
Not rated: 0

How lean is counted

Source quality

Average reliability: 65/100 (Mostly factual)
Low-credibility outlets: 0%
State media: 0%
Opinion pieces: 0%

Where ratings come from

Where the coverage comes from

United States1

In this story

Medscape News Europe

Filter the stories

Sources Ratings and details

Oncotype DX Helps Avoid Unnecessary Chemo in Breast Cancer

Summary

Who is covering this

Comments

Summary

Who is covering this

Comments

Related stories

Early Treatment May Delay Rheumatoid Arthritis

Functional Dyspepsia: Why Treatment Must Be Tailored

Can Europe Keep Up With the Next Wave of Synthetic Opioids?

Europe Targets Persistent Gaps in Cardiovascular Prevention

Why Do Kidney Disease and Heart Failure Go Together?

Glutathione Supplements: Health Benefits or Just Hype?